Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| erythrocyte | 9 studies | 47% ± 17% | |
| erythroblast | 4 studies | 35% ± 25% | |
| endothelial cell | 4 studies | 22% ± 3% | |
| glutamatergic neuron | 3 studies | 31% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adipose | 95% | 189.99 | 1138 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 89% | 362.73 | 215 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 81% | 3163.98 | 756 / 929 | 0% | 0 | 0 / 0 |
| breast | 70% | 88.00 | 322 / 459 | 1% | 0.01 | 8 / 1118 |
| lung | 58% | 54.38 | 336 / 578 | 0% | 0.01 | 4 / 1155 |
| liver | 30% | 20.38 | 67 / 226 | 0% | 0.01 | 1 / 406 |
| kidney | 27% | 13.43 | 24 / 89 | 1% | 0.07 | 10 / 901 |
| thymus | 23% | 11.80 | 148 / 653 | 0% | 0.00 | 1 / 605 |
| heart | 22% | 13.70 | 191 / 861 | 0% | 0 | 0 / 0 |
| ovary | 17% | 9.59 | 30 / 180 | 0% | 0.00 | 1 / 430 |
| blood vessel | 15% | 13.04 | 199 / 1335 | 0% | 0 | 0 / 0 |
| brain | 8% | 2.74 | 217 / 2642 | 0% | 0 | 0 / 705 |
| esophagus | 6% | 2.54 | 83 / 1445 | 1% | 0.01 | 1 / 183 |
| adrenal gland | 4% | 1.36 | 11 / 258 | 2% | 0.11 | 4 / 230 |
| intestine | 5% | 2.40 | 45 / 966 | 0% | 0.01 | 2 / 527 |
| bladder | 5% | 1.10 | 1 / 21 | 0% | 0 | 0 / 504 |
| skin | 4% | 1.70 | 77 / 1809 | 0% | 0 | 0 / 472 |
| stomach | 3% | 1.25 | 9 / 359 | 0% | 0.01 | 1 / 286 |
| muscle | 3% | 0.99 | 22 / 803 | 0% | 0 | 0 / 0 |
| uterus | 2% | 0.84 | 3 / 170 | 0% | 0 | 0 / 459 |
| prostate | 2% | 0.47 | 4 / 245 | 0% | 0 | 0 / 502 |
| pancreas | 1% | 0.16 | 2 / 328 | 0% | 0 | 0 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008360 | Biological process | regulation of cell shape |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0020027 | Biological process | hemoglobin metabolic process |
| GO_0018149 | Biological process | peptide cross-linking |
| GO_0048536 | Biological process | spleen development |
| GO_0060586 | Biological process | multicellular organismal-level iron ion homeostasis |
| GO_0007010 | Biological process | cytoskeleton organization |
| GO_0043249 | Biological process | erythrocyte maturation |
| GO_0030863 | Cellular component | cortical cytoskeleton |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0170014 | Cellular component | ankyrin-1 complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005200 | Molecular function | structural constituent of cytoskeleton |
| GO_0005515 | Molecular function | protein binding |
| GO_0003810 | Molecular function | protein-glutamine gamma-glutamyltransferase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | EPB42 |
| Protein name | Protein 4.2 (P4.2) (Erythrocyte membrane protein band 4.2) (Erythrocyte protein 4.2) Erythrocyte membrane protein band 4.2 EPB42 protein |
| Synonyms | E42P |
| Description | FUNCTION: Component of the ankyrin-1 complex, a multiprotein complex involved in the stability and shape of the erythrocyte membrane. . |
| Accessions | F5H563 Q4VB96 ENST00000569204.1 H3BPV8 ENST00000540029.5 ENST00000565459.1 P16452 ENST00000441366.7 [P16452-1] H3BUR1 ENST00000648595.1 [P16452-2] |